HRS 22: Intensive vs Standard BP Treatment in Patients With LV Conduction Disease | Dr Møeller

Подробнее о видео

Watch on Radcliffe Cardiology:

In this short interview video from HRS 2022, Dr Emilie Møller (University of California San Francisco, San Francisco, CA, US) discusses the findings from a recent study which aimed to determine the effects of intensive blood pressure treatment compared to usual care in patients with incident left-ventricular conduction disease.

Discussion points:
1. Aim, study design and endpoints
2. Main findings
3. Impact on clinical practice
4. Patient eligibility
5. Take-home messages for clinicians
6. Next steps

Recorded onsite at HRS 2022, San Francisco.
This content is intended for healthcare professionals only.

Radcliffe brings medical knowledge, insight and innovation to life for CV clinicians around the world, using our communications & creative expertise, our platforms and connections across the community to help transform theory into practice faster.